GO
Loading...

Pfizer Inc

More

  • Final Glance: Pharmaceuticals companies Monday, 27 Apr 2015 | 6:06 PM ET

    Baxter International Inc. fell$. 77 or 1.1 percent, to $70.37. Bristol-Myers Squibb Co. fell$. 64 or 1.0 percent, to $65.16. Johnson& Johnson fell$. 50 or. 5 percent, to $100.58.

  • Most active New York Stock Exchange-traded stocks Monday, 27 Apr 2015 | 1:50 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at the close of trading:. AT&T Inc. rose. 2 percent to $34.09 with 21,248,400 shares traded. Alcoa Inc. rose 1.7 percent to $13.45 with 28,193,600 shares traded.

  • Midday Glance: Pharmaceuticals companies Monday, 27 Apr 2015 | 1:50 PM ET

    Baxter International Inc. fell$. 46 or. 6 percent, to $70.68. Bristol-Myers Squibb Co. fell$. 55 or. 8 percent, to $65.25. Eli Lilly& Co. fell$. 61 or. 9 percent, to $70.97.

  • *Further gains in biotech, social media seen limited. *Investors view cyber security, cloud services as growth areas. NEW YORK, April 27- When the Nasdaq Composite last hit record highs during the dotcom era, fund manager Walter Price struggled with justifying paying 400 times a company's earnings for rapid growth.

  • LONDON, April 27- Britain's warning to potential suitors of BP is a sign of the oil major's vulnerability to a takeover bid and that a more politically palatable tie-up with Royal Dutch Shell no longer seems to be an option, banking and industry sources said. Despite championing a laissez-faire policy towards takeover deals, Britain has always had a special...

  • Early Glance: Pharmaceuticals companies Monday, 27 Apr 2015 | 11:25 AM ET

    Baxter International Inc. rose$. 15 or. 2 percent, to $71.29. Bristol-Myers Squibb Co. rose$. 16 or. 2 percent, to $65.96. Eli Lilly& Co. rose$. 09 or. 1 percent, to $71.67.

  • *Celladon trial failure shows field remains high-risk. LONDON, April 27- GlaxoSmithKline is close to seeking European approval for a gene therapy drug to fight the immune deficiency disorder known as "bubble boy" disease, in the latest sign of a renaissance in the technology to fix faulty genes. Gene therapy last year won $3.0 billion of financing, up 510 percent on...

  • NEW YORK— U.S. stocks slumped on Monday as investors looked ahead to a flood of earnings reports this week. Stocks appeared headed for new highs in the morning, but drifted lower in afternoon as health care companies dropped sharply. With little news moving markets, "I think we have some profit-taking here," said chief stock strategist Phil Orlando, of Federated...

  • Asian markets rise after Wall Street gains Sunday, 26 Apr 2015 | 11:42 PM ET

    BEIJING— Asian stock markets rose Monday after Wall Street gained on strong earnings and investors looked ahead to Apple results and this week's U.S. Sydney's S&P ASX 200 added 0.7 percent to 5,973.30 and Seoul advanced 0.2 percent to 2,163.17. Taiwan, Singapore and Manila also rose.

  • Correction protection. 3 best Street ideas on week Saturday, 25 Apr 2015 | 7:00 AM ET
    Traders work on the floor of the New York Stock Exchange.

    CNBC Pro highlights the three best strategy notes that came across our desk this week.

  • Final Glance: Pharmaceuticals companies Friday, 24 Apr 2015 | 8:08 PM ET

    Baxter International Inc. fell$. 37 or. 5 percent, to $71.14. Bristol-Myers Squibb Co. fell$. 20 or. 3 percent, to $65.80. Eli Lilly& Co. fell$. 82 or 1.1 percent, to $71.58.

  • NEW YORK, April 24- Healthcare companies on a seven-year tear have been top performers so far in 2015, helping to push broad stock indexes to record levels, but traders are now looking to protect themselves from a selloff as they await major earnings reports in the sector. Companies reporting first-quarter earnings next week include Bristol-Meyers Squibb Co,...

  • Midday Glance: Pharmaceuticals companies Friday, 24 Apr 2015 | 1:36 PM ET

    Baxter International Inc. fell$. 39 or. 5 percent, to $71.12. Bristol-Myers Squibb Co. fell$. 28 or. 4 percent, to $65.72. Eli Lilly& Co. fell$. 98 or 1.4 percent, to $71.42.

  • Most active New York Stock Exchange-traded stocks Friday, 24 Apr 2015 | 1:36 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at 1 p.m.:. AT&T Inc. rose. 1 percent to $34.27 with 24,327,600 shares traded. Bank of America Corp. fell. 3 percent to $15.65 with 22,512,500 shares traded.

  • Early Glance: Pharmaceuticals companies Friday, 24 Apr 2015 | 10:55 AM ET

    Baxter International Inc. fell$. 42 or. 6 percent, to $71.09. Bristol-Myers Squibb Co. fell$. 11 or. 2 percent, to $65.89. Pfizer fell$. 11 or. 3 percent, to $35.25.

  • Comcast's failed $45 billion deal for Time Warner Cable is a high-profile example of a failed deal, but it doesn't crack the list of the 10 largest. That distinction belongs to an unsolicited, $79.6 billion bid for Time Warner Inc. made by Rupert Murdoch's 21st Century Fox, according to financial data provider Dealogic. Time Warner Inc. spun off Time Warner Cable...

  • Stocks rise on tech earnings; Nasdaq adds to record Friday, 24 Apr 2015 | 4:43 AM ET

    NEW YORK— Stocks advanced slightly Friday as investors cheered the quarterly results of three large technology companies: Google, Microsoft and Amazon. Next week, more than 150 companies in the S&P 500 will report their results, including such market-moving names as Apple, Ford, Visa, Pfizer and Exxon Mobil. Microsoft, Amazon and Google all rose sharply after the...

  • AstraZeneca eyes new cancer deals after Nexium hit Friday, 24 Apr 2015 | 3:35 AM ET
    British pharmaceutical company AstraZeneca's manufacturing site in Macclesfield, northwest England.

    AstraZeneca has sharpened its focus on cancer drugs as it looks beyond a hit to sales from the launch of cheap copies of its acid pill Nexium.

  • LONDON, April 24- AstraZeneca has sharpened its focus on cancer drugs with two new deals as it looks beyond a hit to sales and profits from the launch of cheap copies of its popular stomach acid pill Nexium in the vital U.S. market. AstraZeneca will get an upfront payment of $450 million from Celgene, while Innate will receive an initial $250 million from...

  • Final Glance: Pharmaceuticals companies Thursday, 23 Apr 2015 | 6:05 PM ET

    Baxter International Inc. rose $1.13 or 1.6 percent, to $71.51. Bristol-Myers Squibb Co. fell$. 60 or. 9 percent, to $66.00. Eli Lilly& Co. rose$. 10 or. 1 percent, to $72.40.